Business Context and Reporting Period
This Form 10-Q covers II-VI Incorporated (noting the metadata reference to Coherent Corp. is inconsistent with the filing text which identifies the registrant as II-VI Incorporated) for the quarterly period ended September 30, 1997. The company operates in the manufacturing of infrared optics, materials, and related products, with significant operations in the United States and internationally.
Key Financial Metrics
| Metric | Q1 FY1998 (Sep 30, 1997) | Q1 FY1997 (Sep 30, 1996) |
|---|---|---|
| Total Revenues | $15,519,000 | $12,110,000 |
| Net Earnings | $2,112,000 | $1,660,000 |
| Earnings Per Share | $0.32 | $0.25 |
| Manufacturing Gross Margin | 44% ($6,575,000) | 45% ($5,244,000) |
| Cash and Equivalents (End of Period) | $7,097,000 | $8,606,000 |
| Net Cash Used in Operating Activities | ($958,000) | $131,000 |
| Capital Expenditures | $4,926,000 | $1,407,000 |
| Total Debt (Current + Long-Term) | $3,497,000 | Filing text does not provide a clear comparative total for 1996 |
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 28% year-over-year, driven primarily by an 80% contribution from increased shipments of infrared optics and materials, with the remainder from the VLOC subsidiary.
- Order Bookings: Order bookings rose 24% to $16.05 million. Excluding long-term R&D contracts, manufacturing bookings increased 35%.
- Profitability: Net earnings increased 27% to $2.11 million. However, the manufacturing gross margin percentage declined slightly from 45% to 44% due to a strengthening U.S. dollar and increased expenses in the eV PRODUCTS division.
- Cash Flow: Operating cash flow turned negative ($958,000 used) compared to a positive $131,000 in the prior year. This was driven by increased working capital needs (accounts receivable and inventory) and significant payments for prior-year profit-sharing bonuses.
- Capital Spending: Capital expenditures surged to $4.93 million, a 250% increase from the prior year, focused on new manufacturing facilities in Florida and Pennsylvania.
Outlook, Risks, and Management Commentary
- Liquidity Strategy: Management plans to fund future working capital, capital expenditures, and debt payments using existing cash reserves (including a new $1.98 million low-interest loan from PNC Bank) and internally generated funds. Potential acquisitions are also under consideration.
- Operational Drivers: The company is expanding capacity to fulfill major orders, specifically citing a large order from Neoprobe Corporation which impacted the eV PRODUCTS division's expenses.
- Risks and Contingencies: Forward-looking statements are subject to risks including changes in worldwide economic conditions, intensified competition, technology problems, and the inability to consummate suitable acquisitions. The filing references risk factors detailed in the 1997 Form 10-K.
- Accounting Changes: The company notes the upcoming adoption of SFAS No. 128 (Earnings Per Share) effective for periods ending after December 15, 1997, which will require restatement of prior-period EPS data.
Investor Verification Checklist
- Verify the sustainability of the 28% revenue growth and the specific contribution of the Neoprobe Corporation order to future quarters.
- Monitor the impact of the strengthening U.S. dollar on future gross margins, given the company's significant international revenue exposure.
- Assess the timeline for the new manufacturing facilities in Florida and Pennsylvania to become operational and generate returns on the $4.9 million capital investment.
- Review the company's ability to generate positive operating cash flow in subsequent quarters to offset the current negative operating cash flow and fund ongoing expansion.
- Confirm the terms and covenants of the new $1.98 million PNC Bank loan and its impact on future debt service obligations.